BMED
name pending profile ingest
All ownership figures: tracked 13F managers only, common-stock positions, reporting period Q4 2024
| Quarter | Holders | Δ | Shares | Reported value | New | Exits |
|---|---|---|---|---|---|---|
| Q2 2026 | 2 | -1 | 11.11K | $340,034 | — | −1 |
| Q1 2026 | 4 | 0 | 29.54K | $854,397 | — | — |
| Q4 2025 | 4 | 0 | 30.41K | $921,546 | — | — |
| Q3 2025 | 1 | 0 | 9.09K | $243,689 | — | — |
| Q2 2025 | 1 | 0 | 33.43K | $829,139 | — | — |
| Q1 2025 | 1 | 0 | 9.77K | $236,791 | — | — |
| Q4 2024 | 1 | 0 | 8.74K | $217,557 | — | — |
| Q3 2024 | 1 | 0 | 37.55K | $981,129 | — | — |
| Q2 2024 | 1 | — | 20.27K | $507,399 | — | — |
| # | Manager | Shares | Δ shares | Value | Their weight | Held | ||
|---|---|---|---|---|---|---|---|---|
| 1 | Citadel Advisors ✦ | 8.74K | -76.7% | $217,557 | 0.0% | ▼ Trim | 3 | SEC ↗ |
“Their weight” = the position's share of that manager's reported 13F equity value — the conviction measure. ✦ = curated manager.
New buyers
| No new tracked buyers this quarter. |
Exited
| No tracked exits this quarter. |
Full-market context: across ALL 13F filers (SEC structured data, Q1 2026): 6 holders, 57.03K shares, $1.65M reported. This is a different, older period than the tracked-universe figures above and the two are never mixed.
What else this security's tracked holders most often hold — shared-ownership counts, not fundamental relationships.